Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
Anti–PD-1 antibodies recognizing the membrane-proximal region are PD-1 agonists that can down-regulate inflammatory diseases | Science Immunology
Advancing Precision Medicine: In Vitro Potency Assays for Evaluating the Function of anti-PD-1 Checkpoint Inhibitors
Agonistic anti-PD-1 antibodies turn on the immunosuppressive activity of PD- 1
Schematic representation of PD-1 and anti-PD-1/PD-L1 mechanisms of... | Download Scientific Diagram
PD1 Antibody Selection Tool | Bio X Cell
The role of anti-PD-1 and anti-PD-L1 agents in the treatment of diffuse large B-cell lymphoma: The future is now - ScienceDirect
Frontiers | Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC
Anti-PD-1 Inhibitors – Melanoma Unit
PD-1
Frontiers | PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake
Frontiers | Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
Current issues and perspectives in PD-1 blockade cancer immunotherapy | International Journal of Clinical Oncology
PDL1 e immunoterapici | L'immunologo risponde | alcase.eu
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study - The Lancet Oncology
IJMS | Free Full-Text | PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy
Frontiers | Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics | Journal of Hematology & Oncology | Full Text
News
JCI - TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis
PD-1
PD-1/L1 e anti-PD-1: test per il dosaggio della molecola e del farmaco – Listarfish.it – PRODOTTI PER RICERCA & DIAGNOSTICA
The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer: Molecular Therapy
Anti-hPD-1 antibodies | Pembrolizumab & Nivolumab biosimilar isotypes | InvivoGen
JCM | Free Full-Text | Anti-PD-1 and Novel Combinations in the Treatment of Melanoma—An Update
Emerging Role of Ubiquitination in the Regulation of PD-1/PD-L1 in Cancer Immunotherapy: Molecular Therapy
